American Academy of Pediatrics Recommends Cholesterol Drugs in Kids

by Rajashri on  July 7, 2008 at 2:25 PM Child Health News   - G J E 4
 American Academy of Pediatrics Recommends Cholesterol Drugs in Kids
The American Academy of Pediatrics is recommending cholesterol lowering drugs in some kids as young as 8 years in order to avoid future problems.

Dr. Stephen Daniels, of the academy's nutrition committee, said the new guidelines were being issued as evidence indicated that damage to the heart begins early in life.

"If we are more aggressive about this in childhood, I think we can have an impact on what happens later in life ... and avoid some of these heart attacks and strokes in adulthood," Daniels said.

The main criteria for recommending drugs for kids will be levels of LDL, the "bad" cholesterol, obesity and high blood pressure.

The AAP also recommends low-fat milk for 1-year-old and routine cholesterol testing for kids.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
Yes....I am appalled! I can't believe that the an Academy of supposedly "intelligent" individuals would take such an asinine position as medicating children who have high cholesterol! Screening children would be helpful. Once screening is done an assessment of their nutritional habits could be done and their diet modified accordingly. To resort to administering statins to children would prove tragic. This idea is a disgrace to nutritionist everywhere! Dr. Jatinder Bhatia,
a member of your "nutrition committee", told the Times: "The risk of giving statins at a lower age is less than the benefit you're going to get out of it." What would be those benefits "Dr." Bhatia? The evidence to back up that quote is miniscule. And that's being generous! In fact, after "Dr."Bhatia" made this "intelligent" risk/benefit statement, he completely weakened his argument by telling the Times there is not "a whole lot" of data on pediatric use of cholesterol-lowering drugs. So, he makes the whole medicate the young idea based on miniscule data?

Okay I got it.... maybe it's time for an Academy name change! How about.....The American Academy for the Protection of Pharmaceutical Profit Margins Who Don't Give A Damn about You or Your Children.

guest Tuesday, July 8, 2008

You May Also Like